Press Releases

Panthera and Rutherford Health launch innovative oncology clinical trial network

Panthera and Rutherford Health launch innovative oncology clinical trial network with expertise across more than 40 types of cancer; access to patients from more than 170 referring oncologists; and state-of-the-art cancer treatment and diagnostic centres.

Sharp Clinical Launches Direct-to-Patient Service with New Partnerships

Sharp Clinical Services, part of UDG Healthcare and a leading provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support programme with its sister company, Ashfield.

Florence Healthcare Names Melinda Rodriguez Winner of The Florence Effect Initiative

Florence Healthcare, the leading platform for remote-enabled electronic document workflow management in clinical trials, is proud to name Melinda Rodriguez, Director of Regulatory Services at Elligo Health Research, as the winner of The Florence Effect initiative.

The University of Aberdeen chooses BridgeHead’s ICA

CORONAVIRUS TEST WINS FUNDING FROM INNOVATE UK

Sugar based technology offers diagnosis on the spot in under 15 minutes

ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials

Combining APDM’s precision motion wearables and digital biomarkers with ERT’s eClinical Suite revolutionizes clinical trials

ArisGlobal Announces the All-New LifeSphere® Regulatory Platform, Bringing Game-Changing Efficiency to Regulatory Information Management

The new LifeSphere Regulatory platform includes LifeSphere® RIMS, a complete solution for managing all core regulatory processes, and LifeSphere® Publishing, a submissions management system that enables life science organizations to easily compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements.

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis

NFX-179 Gel is different from other treatments for neurofibromatosis, both FDA approved and in the pipeline, and this funding and new development highlights the importance of the “soft drug” approach as well as how the $20 M Series A funding from venBio and F-Prime Capital will be used to advance NFlection’s lead program in developing therapies for rare disorders known as RASopathies, including NF1.

AI & Medicine Launches AI-Powered Drug Discovery Platform for the Science Community

On April 21, 2020, AI & Medicine proudly announced that it has successfully developed a unique artificial intelligence (AI) drug discovery platform, offering drug research and development solutions for medical institutions and pharmaceutical enterprises worldwide.

Alfa Chemistry Testing Lab Offers an Exclusive Section for Regulatory Resources

Alfa Chemistry Testing Lab has been adding resources to its website regarding rules and regulations on the broad spectrum of testing and analysis.

The Life Sciences Data Interoperability Revolution is Here with eClinical Solutions’ Expanded Clinical Data Platform

Latest release of elluminate addresses key industry data challenges with expanded connectors to popular clinical systems

Celerion Recognized as 2020 CRO Leadership Champion for Reliability and Receives CRO Leadership Award for Capabilities, Compatibility, Expertise, and Quality

Celerion is proud to announce, for the fifth consecutive year, recognition of its early stage research development services across five categories in the 2020 CRO Leadership Awards.

Panthera Biopartners appoints Chris Dodd as Executive VP of Business Development – Oncology and CNS

Chris Dodd has been appointed as the new Executive VP of Business Development – Oncology and CNS at Panthera Biopartners, an Independent Site Management Organisation based in Preston.

Creative Biolabs Integrates Blood Sample to Its All-inclusive Primate Biobank

Non-human primates are an important medium to understand laws of the organic world. Focusing on preclinical animal research for more than 10 years, Creative Biolabs provides a full range of NHP biological products to clients worldwide.

Celerion Expands HRMS Metabolite Identification Capabilities for Full Service Metabolism Offering

Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product.

Alfa Chemistry Testing Lab Releases Nano-products Safety Evaluation Services

Alfa Chemistry Testing Lab, a professional testing and analysis organization, announced to have released nano-products safety evaluation services for companies and agencies that are engaged with the development and application of nano-products.

Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle

Elucid's smart cap dispenser fits on any medicine bottle

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations. The recent hiring signifies continued strategic growth as firm expands its operations in Philadelphia

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

PRESS RELEASE: Nottingham, UK, June 1, 2020 – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020. This announcement follows the recent appointment of Jonas Skjødt Møller as Chief Executive Officer of Albumedix and is part of the company’s global growth strategy.

UCB and N-SIDE increase their strategic collaboration

N-SIDE announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol design to on-going clinical trials.